Concepedia

Publication | Open Access

PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence

48

Citations

23

References

2020

Year

Abstract

Given the relatively low incidence of immune-related AEs and the comparability of clinical outcomes, ICIs can be treatment option of NSCLC patients with special issues.

References

YearCitations

Page 1